Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:42 PM
Ignite Modification Date:
2025-12-24 @ 3:42 PM
NCT ID:
NCT04653792
Eligibility Criteria:
Inclusion Criteria:
* All patients with severe CLBP and/or leg pain
* Patients with static or dynamic leg pain
* Patients with leg pain resulting from localized lumbar or lumbosacral segmental instability
* Spinal stenosis at levels L2-S1 or caused by isthmic spondylolisthesis (grade I and II)
Exclusion Criteria:
* Patients with previous lumbar surgery
* Patients allergic to gabapentinoids
* Patients with renal impairments
* Patients who are already on opioids, benzodiazepines, barbiturates, ethanol (alcohol)
* Patient presented with diabetes and other drugs that depress the central nervous system
* Patients who are already on ACE inhibitors as they may enhance the adverse/toxic effect of Pregabalin.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
65 Years
Study:
NCT04653792
Study Brief:
Protocol Section:
NCT04653792